← The SEC Ephemeris: the whole map
Apiject Systems Corp. glycopyrrolate
In the graph: all 1 documents (2 pages).
- Application
- NDA 219107
- Ticker
- Apiject Systems Corp.
- Product
- glycopyrrolate
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- July 21, 2026
From FDA letters and SEC filings. Not investment or medical advice.